TCM
DTIL icon

Tang Capital Management’s Precision BioSciences DTIL Stock Holding History

Tang Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-653,649
Closed -$3.61M – 113
2025
Q3 		$3.61M Hold
653,649
– – 0.14% 103
2025
Q2 		$2.75M Sell
653,649
-19,683
-3% -$97.1K 0.14% 112
2025
Q1 		$3.21M Hold
673,332
– – 0.18% 99
2024
Q4 		$2.57M Buy
673,332
+50,000
+8% +$365K 0.17% 97
2024
Q3 		$5.59M Hold
623,332
– – 0.4% 70
2024
Q2 		$6.07M Buy
623,332
+33,763
+6% +$398K 0.62% 50
2024
Q1 		$7.99M Buy
589,569
+476,236
+420% +$5.83M 0.83% 41
2023
Q4 		$1.24M Buy
+113,333
New +$1.22M 0.11% 103

Other funds holding DTIL

EAM
Empery Asset Management New York $83M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Tang Capital Management's DTIL Position: Q4 2025 in Review

Tang Capital Management sold out of Precision BioSciences (DTIL) in Q4 2025, closing a stake of 653,649 shares — an estimated $3.61M sold.

Tang Capital Management first reported a position in DTIL in Q4 2023 and held it in 8 quarters. The position peaked at $7.99M in Q1 2024. 69 funds tracked by Wall St. Rank hold DTIL as of Q4 2025.

  • Tang Capital Management reported no remaining Precision BioSciences position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 653,649 Precision BioSciences shares in Q4 2025, an estimated $3.61M.
  • Tang Capital Management first reported a position in Precision BioSciences in Q4 2023 and held it in 8 quarters.
  • Tang Capital Management's Precision BioSciences position peaked at $7.99M in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.